CUV clinuvel pharmaceuticals limited

Ann: Appendix 4E and Annual Report 2022, page-21

  1. 7,705 Posts.
    lightbulb Created with Sketch. 2797
    LMAO. I was actually referring to the almost 100% failure rate of melanocortin analogue drugs over the past 50 years due to severe side effects.

    Punters here seem totally unaware that orphan drugs for diseases like EPP have much lower safety and efficacy requirements.

    Bitopertin was originally developed by Roche as an antipsychotic. While it had an excellent safety profile it wasn't effective in treating schizophrenia.
    Last edited by PigsMightFly: 01/09/22
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$10.12
Change
-0.260(2.50%)
Mkt cap ! $507.2M
Open High Low Value Volume
$10.58 $10.63 $10.09 $1.117M 108.9K

Buyers (Bids)

No. Vol. Price($)
1 297 $10.10
 

Sellers (Offers)

Price($) Vol. No.
$10.20 360 1
View Market Depth
Last trade - 16.10pm 01/07/2025 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.